Calciphylaxis, also known as calcific uremic arteriolopathy, is a quaint but potentially devastating entity most often observed in patients with end-stage renal disease, although it does occasionally develop in patients without renal failure.
It is characterized by cutaneous arteriolar calcification and subsequent tissue ischemia and infarction causing painful skin lesions.
It is associated with substantial morbidity and is a highly fatal condition with 1-year mortality rates greater than 50 percent, most frequently due to sepsis.
It is strived in this E-Booklet to Identify the risk factors for calciphylaxis, Describe the pathophysiology of calciphylaxis, Outline treatment options available for calciphylaxis and Explain the importance of an interprofessional team approach for the effective treatment along with several relevant IMAGES for better understanding.